ArticleEuropean radiology2026
CT-guided core needle biopsy in ultrasound-inaccessible suprahyoid deep neck spaces.
Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo assess the diagnostic yield, procedural safety, and concordance with reference standards of CT-guided core needle biopsy (CNB) for ultrasound-inaccessible lesions in the suprahyoid deep neck spaces. MATERIALS AND
methodsIn this retrospective single-center cohort study, 122 CT-guided core needle biopsies in 118 patients between January 2005 and August 2024 were evaluated. Patients lost to follow-up were excluded (n = 9). Procedural characteristics, diagnostic performance, procedural safety, and concordance with surgical pathology were analyzed.
resultsOf the 118 included patients, the median age was 59 years, and 70 patients (59.3%) were female. Among 122 CT-guided CNBs, 115 (94.3%) were performed in the suprahyoid deep neck spaces. The diagnostic yield was 93.4% (114/122; 95% CI: 87.6%-96.6%). The histopathologic concordance between CT-guided CNB and surgery was 89.5% (34/38). Minor procedure-related complications occurred in 4.1% (5/122) of all cases.
conclusionsCT-guided CNB is a reliable diagnostic tool for ultrasound-inaccessible lesions in the suprahyoid deep neck spaces, where complex anatomy may limit needle visualization with ultrasound guidance. These findings support the selective use of CT guidance for tissue diagnosis in anatomically challenging head and neck lesions. KEY POINTS: Question What are the diagnostic yield, procedural safety, and concordance of CT-guided CNB for ultrasound-inaccessible lesions in the suprahyoid head and neck? Findings CT-guided CNB demonstrated a diagnostic yield of 93.4%, surgical concordance of 89.5%, and a minor complication rate of 4.1% in a cohort of suprahyoid lesions. Clinical relevance CT-guided CNB can provide reliable tissue diagnosis for ultrasound-inaccessible lesions in the suprahyoid head and neck. It may serve as a complementary diagnostic tool for anatomically challenging cases in which ultrasound-guided biopsy is not feasible.
Indexed as
Identifiers
42803938What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.